Prediction of gestational diabetes mellitus by unconjugated estriol levels in maternal serum

Junguk Hur, Eun Hee Cho, Kwang Hyun Baek, Kyung Ju Lee

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


The aim of this study was to evaluate the association between maternal serum estriol levels, which are routinely measured in the first trimester of pregnancy, and adverse pregnancy outcomes including gestational diabetes. We performed a retrospective chart analysis of women who delivered between July 1, 2007, and December 31, 2009, at Kangnam CHA Medical Center in Seoul, Korea. Only patients with available estriol measurements during their pregnancies and complete follow-up data were included in the study. The effect of estriol on the incidence of adverse pregnancy outcomes was examined using multinomial logistic regression analysis with age and pre-pregnancy body mass index (BMI) as covariates. The total number of subjects was 1,553, the mean age was 32.9 ± 3.7 years, and the mean pre-pregnancy BMI was 21.2 ± 3.0 kg/m2. Unconjugated estriol > 95th percentile of the screened population or unconjugated estriol ≥ 2.0 MoM (Multiple of the Median) was significantly associated with an increased risk for developing gestational diabetes mellitus (GDM), after adjusting for age and pre-pregnancy maternal weight. High levels of unconjugated estriol in the maternal serum during the early second trimester of pregnancy are a useful predictor of GDM development.

Original languageEnglish (US)
Pages (from-to)123-127
Number of pages5
JournalInternational Journal of Medical Sciences
Issue number2
StatePublished - Feb 7 2017
Externally publishedYes


  • Estriol
  • Gestational diabetes
  • Pregnancy outcomes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Prediction of gestational diabetes mellitus by unconjugated estriol levels in maternal serum'. Together they form a unique fingerprint.

Cite this